# Palomar Holdings, Inc.: financial statements, quarterly

PLMR · Nasdaq · CIK 1761312 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/plmr.md) · [Financials](/companies/plmr/financials.md) · [Filings](/companies/plmr/filings.md) · [Insiders](/companies/plmr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/plmr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [90.9](/filings/0001437749-24-033403.md) | [105 d](/filings/0001193125-26-067364.md) | [119](/filings/0001437749-25-014835.md) | [131](/filings/0000950170-25-103234.md) | [149](/filings/0001193125-25-272277.md) | [156 d](/filings/0001193125-26-067364.md) | [175](/filings/0001193125-26-212569.md) | [203](/filings/0001193125-26-335508.md) | [245](/filings/0001193125-25-272277.md) | [253 d](/filings/0001193125-26-067364.md) | [279](/filings/0001193125-26-212569.md) | [314](/filings/0001193125-26-335508.md) |
| Interest expense | $m | [0.9](/filings/0001437749-24-033403.md) | [0.8 d](/filings/0001193125-26-067364.md) | [0.7](/filings/0001437749-25-014835.md) | [0.2](/filings/0000950170-25-103234.md) | [0.1](/filings/0001193125-25-272277.md) | [0.1 d](/filings/0001193125-26-067364.md) | [0.1](/filings/0001193125-26-212569.md) | [0.1](/filings/0001193125-26-335508.md) | [0.1](/filings/0001193125-25-272277.md) | [0.1 d](/filings/0001193125-26-067364.md) | [3.2](/filings/0001193125-26-212569.md) | [4.9](/filings/0001193125-26-335508.md) |
| Income tax | $m | [6.1](/filings/0001437749-24-033403.md) | [7.6 d](/filings/0001193125-26-067364.md) | [8.0](/filings/0001437749-25-014835.md) | [7.6](/filings/0000950170-25-103234.md) | [8.0](/filings/0001193125-25-272277.md) | [10.0 d](/filings/0001193125-26-067364.md) | [10.8](/filings/0001193125-26-212569.md) | [13.4](/filings/0001193125-26-335508.md) | [15.7](/filings/0001193125-25-272277.md) | [16.5 d](/filings/0001193125-26-067364.md) | [10.5](/filings/0001193125-26-212569.md) | [17.2](/filings/0001193125-26-335508.md) |
| Net income | $m | [18.4](/filings/0001437749-24-033403.md) | [25.9 d](/filings/0001193125-26-067364.md) | [26.4](/filings/0001193125-25-272277.md) | [25.7](/filings/0001193125-25-272277.md) | [30.5](/filings/0001193125-25-272277.md) | [35.0 d](/filings/0001193125-26-067364.md) | [42.9](/filings/0001193125-26-335508.md) | [46.5](/filings/0001193125-26-335508.md) | [51.5](/filings/0001193125-25-272277.md) | [56.2 d](/filings/0001193125-26-067364.md) | [42.9](/filings/0001193125-26-335508.md) | [52.6](/filings/0001193125-26-335508.md) |
| Diluted EPS | $ per share | [0.73](/filings/0001437749-24-033403.md) | not reported | [1.04](/filings/0001437749-25-014835.md) | [1.00](/filings/0000950170-25-103234.md) | [1.15](/filings/0001193125-25-272277.md) | not reported | [1.57](/filings/0001193125-26-212569.md) | [1.68](/filings/0001193125-26-335508.md) | [1.87](/filings/0001193125-25-272277.md) | not reported | [1.57](/filings/0001193125-26-212569.md) | [1.94](/filings/0001193125-26-335508.md) |
| Basic EPS | $ per share | [0.75](/filings/0001437749-24-033403.md) | not reported | [1.06](/filings/0001437749-25-014835.md) | [1.03](/filings/0000950170-25-103234.md) | [1.18](/filings/0001193125-25-272277.md) | not reported | [1.61](/filings/0001193125-26-212569.md) | [1.74](/filings/0001193125-26-335508.md) | [1.93](/filings/0001193125-25-272277.md) | not reported | [1.62](/filings/0001193125-26-212569.md) | [2.00](/filings/0001193125-26-335508.md) |

- Revenue: us-gaap:Revenues
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [53.0](/filings/0001437749-23-030041.md) | [51.5](/filings/0001437749-25-005069.md) | [61.4](/filings/0001437749-24-014682.md) | [47.8](/filings/0001437749-24-024910.md) | [86.5](/filings/0001437749-24-033403.md) | [80.4](/filings/0001193125-26-067364.md) | [119](/filings/0001437749-25-014835.md) | [81.3](/filings/0000950170-25-103234.md) | [112](/filings/0001193125-25-272277.md) | [107](/filings/0001193125-26-335508.md) | [56.5](/filings/0001193125-26-212569.md) | [62.7](/filings/0001193125-26-335508.md) |
| Total assets | $m | [1,626](/filings/0001437749-23-030041.md) | [1,708](/filings/0001437749-25-005069.md) | [1,885](/filings/0001437749-24-014682.md) | [2,016](/filings/0001437749-24-024910.md) | [2,276](/filings/0001437749-24-033403.md) | [2,262](/filings/0001193125-26-067364.md) | [2,427](/filings/0001437749-25-014835.md) | [2,832](/filings/0000950170-25-103234.md) | [2,944](/filings/0001193125-25-272277.md) | [3,051](/filings/0001193125-26-335508.md) | [3,612](/filings/0001193125-26-212569.md) | [3,964](/filings/0001193125-26-335508.md) |
| Total liabilities | $m | [1,205](/filings/0001437749-23-030041.md) | [1,237](/filings/0001437749-25-005069.md) | [1,383](/filings/0001437749-24-014682.md) | [1,483](/filings/0001437749-24-024910.md) | [1,573](/filings/0001437749-24-033403.md) | [1,533](/filings/0001193125-26-067364.md) | [1,636](/filings/0001437749-25-014835.md) | [1,985](/filings/0000950170-25-103234.md) | [2,065](/filings/0001193125-25-272277.md) | [2,108](/filings/0001193125-26-335508.md) | [2,653](/filings/0001193125-26-212569.md) | [2,983](/filings/0001193125-26-335508.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001193125-26-212569.md) | [297](/filings/0001193125-26-212569.md) | [296](/filings/0001193125-26-335508.md) |
| Shareholders' equity | $m | [421](/filings/0001437749-23-030041.md) | [471](/filings/0001193125-26-067364.md) | [502](/filings/0001193125-25-272277.md) | [533](/filings/0001193125-25-272277.md) | [703](/filings/0001193125-25-272277.md) | [729](/filings/0001193125-26-335508.md) | [790](/filings/0001193125-26-335508.md) | [847](/filings/0001193125-26-335508.md) | [878](/filings/0001193125-25-272277.md) | [943](/filings/0001193125-26-335508.md) | [959](/filings/0001193125-26-335508.md) | [981](/filings/0001193125-26-335508.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [70.6 d](/filings/0001437749-24-033403.md) | [22.3 d](/filings/0001193125-26-067364.md) | [33.1](/filings/0001437749-25-014835.md) | [55.1 d](/filings/0000950170-25-103234.md) | [100 d](/filings/0001193125-25-272277.md) | [72.6 d](/filings/0001193125-26-067364.md) | [87.2](/filings/0001193125-26-212569.md) | [121 d](/filings/0001193125-26-335508.md) | [83.6 d](/filings/0001193125-25-272277.md) | [117 d](/filings/0001193125-26-067364.md) | [47.0](/filings/0001193125-26-212569.md) | [167 d](/filings/0001193125-26-335508.md) |
| Capital expenditure | $m | [(0.0) d](/filings/0001437749-24-033403.md) | [0.0 d](/filings/0001193125-26-067364.md) | [0.0](/filings/0001437749-25-014835.md) | [0.0 d](/filings/0000950170-25-103234.md) | [0.2 d](/filings/0001193125-25-272277.md) | [0.0 d](/filings/0001193125-26-067364.md) | [0.0](/filings/0001193125-26-212569.md) | [0.0 d](/filings/0001193125-26-335508.md) | [0.1 d](/filings/0001193125-25-272277.md) | [0.0 d](/filings/0001193125-26-067364.md) | [0.0](/filings/0001193125-26-212569.md) | [0.4 d](/filings/0001193125-26-335508.md) |
| Share repurchases | $m | [6.6 d](/filings/0001437749-24-033403.md) | [0.1 d](/filings/0001193125-26-067364.md) | [0.0](/filings/0001437749-24-014682.md) | [0.0 d](/filings/0001437749-24-024910.md) | [0.0 d](/filings/0001193125-25-272277.md) | [0.0 d](/filings/0001193125-26-067364.md) | [0.0](/filings/0001193125-26-212569.md) | [0.0 d](/filings/0001193125-26-335508.md) | [37.3 d](/filings/0001193125-25-272277.md) | [0.0 d](/filings/0001193125-26-067364.md) | [23.1](/filings/0001193125-26-212569.md) | [41.0 d](/filings/0001193125-26-335508.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [25.8](/filings/0001437749-23-030041.md) | [25.4](/filings/0001437749-24-014682.md) | [25.3](/filings/0001437749-24-024910.md) | [25.2](/filings/0001437749-24-033403.md) | [25.5](/filings/0001437749-25-014835.md) | [25.6](/filings/0000950170-25-103234.md) | [26.5](/filings/0001193125-25-272277.md) | [27.4](/filings/0001193125-26-212569.md) | [27.6](/filings/0001193125-26-335508.md) | [27.4](/filings/0001193125-25-272277.md) | [27.3](/filings/0001193125-26-212569.md) | [27.1](/filings/0001193125-26-335508.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 26,317,683 at 2026-08-02, from the cover of the [10-Q filed 2026-08-05](/filings/0001193125-26-335508.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.